ANTICANCER COMBINATION THERAPY WITH CD73 ANTAGONIST ANTIBODY AND PD-1/PD-L1 AXIS ANTAGONIST ANTIBODY

Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of a CD73 antagonistic antibody alone or in combination with a PD-1/PD-L1 axis antagonist antibody. L'invention concerne des méthodes de traitement du cancer,...

Full description

Saved in:
Bibliographic Details
Main Authors POSTELNEK, Jennifer R, ALTURA, Rachel A, PEREZ, Raymond P, KLIPPEL-GIESE, Anke, HILT, Edward, ZHAO, Yue, SANGHAVI, Kinjal
Format Patent
LanguageEnglish
French
Published 17.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of a CD73 antagonistic antibody alone or in combination with a PD-1/PD-L1 axis antagonist antibody. L'invention concerne des méthodes de traitement du cancer, comprenant l'administration à un sujet atteint d'un cancer d'une quantité thérapeutiquement efficace d'un anticorps antagoniste de CD73 seul ou combiné à un anticorps antagoniste de l'axe PD-1/PD-L1.
AbstractList Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of a CD73 antagonistic antibody alone or in combination with a PD-1/PD-L1 axis antagonist antibody. L'invention concerne des méthodes de traitement du cancer, comprenant l'administration à un sujet atteint d'un cancer d'une quantité thérapeutiquement efficace d'un anticorps antagoniste de CD73 seul ou combiné à un anticorps antagoniste de l'axe PD-1/PD-L1.
Author ALTURA, Rachel A
SANGHAVI, Kinjal
PEREZ, Raymond P
HILT, Edward
ZHAO, Yue
KLIPPEL-GIESE, Anke
POSTELNEK, Jennifer R
Author_xml – fullname: POSTELNEK, Jennifer R
– fullname: ALTURA, Rachel A
– fullname: PEREZ, Raymond P
– fullname: KLIPPEL-GIESE, Anke
– fullname: HILT, Edward
– fullname: ZHAO, Yue
– fullname: SANGHAVI, Kinjal
BookMark eNrjYmDJy89L5WRIcfQL8XR29HN2DVJw9vd18vRzDPH091MI8XANcgyIVAj3DPFQcHYxN1YAKnR09_fzDA4BMT2d_F0igQwXhQAXXUN9IOFjqOAY4RmMTR0PA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYkP9zcyMLQ0MjAwMjVzNDQmThUAPA82rw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate THÉRAPIE COMBINÉE ANTICACNER AVEC UN ANTAGONISTE DE CD73 ET UN ANTAGONISTE DE L'AXE PD-1/PD-L1
ExternalDocumentID WO2019200256A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2019200256A13
IEDL.DBID EVB
IngestDate Fri Sep 27 05:22:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2019200256A13
Notes Application Number: WO2019US27219
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191017&DB=EPODOC&CC=WO&NR=2019200256A1
ParticipantIDs epo_espacenet_WO2019200256A1
PublicationCentury 2000
PublicationDate 20191017
PublicationDateYYYYMMDD 2019-10-17
PublicationDate_xml – month: 10
  year: 2019
  text: 20191017
  day: 17
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.2373877
Snippet Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of a CD73 antagonistic...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Title ANTICANCER COMBINATION THERAPY WITH CD73 ANTAGONIST ANTIBODY AND PD-1/PD-L1 AXIS ANTAGONIST ANTIBODY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191017&DB=EPODOC&locale=&CC=WO&NR=2019200256A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD4heH1T1HhBs0Szt4VdwI0HYrZ2uBnZFpgCT4RuJTExg8iMf9_TCsqD4aVpT5umbXr69Wt7TgHumJHrCHO5ljOdaU2b6drU5DON6TOnbTpTZmaCKPai--Cl-TRqjSrwvraFkX5Cv6RzRNSoDPW9lOv14u8Qi8q3lcsGe0PR_KGbdqi6YsdIPnCGqdTr-ElMY6ISgrxNjfoyz5QA7yJX2hEbaeFp33_1hF3KYhNUukewm2B9RXkMFV7U4ICs_16rwX5vdeVdgz35RjNbonClh8sTyN0oFX81Er-vkLjnhT9ObZU08PtuMlaGYRoohNqWggXdxzgKB6mIhl5MxxihSkI1o4HBs6G4o3DwX7lTuO36KQk0bPjkd5wmw3izl9YZVIt5wc9BaU_5jHM7sxhqX6vJHJ23rSzjyJYsmzv8Aurbarrcnn0FhyIpFnTDrkO1_Pjk14jUJbuRA_wNVDuOjw
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_MA3RY0fqE00e1sYG7jxQMzWDTdlH4Ep8EToVhITM4jM-O97q6A8GF6a5q65tE3vLr_2egdwxxqpgm4ulVOmMLmpM0WeqnwmM2VmtFVjytSkAIp-cO--NJ9GrVEJ3td_YUSe0C-RHBE1KkF9z4W9XvxdYtkitnJZZ29Imj90444trdAxgg88YZJtdZwotEMqUYq4TQr6gqcKB28iVtrRERQWmfadV6v4l7LYdCrdQ9iNUF6WH0GJZ1Wo0HXttSrs-6sn7yrsiRjNZInElR4ujyE1g7io1UidPqGhb3k_SW1J7Dp9MxqToRe7hNq6RnCg-RgG3iAuup4V2mPs2CSy5UYdm16DmCNv8N-4E7jtOjF1ZZz45HefJsNwc5XaKZSzecbPgLSnfMa5nmgMta_VZIbC21qScERLms4Nfg61bZIutrNvoOLGfm_S84LnSzgoWIVxb-g1KOcfn_wKvXbOrsVmfwMlbJF6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTICANCER+COMBINATION+THERAPY+WITH+CD73+ANTAGONIST+ANTIBODY+AND+PD-1%2FPD-L1+AXIS+ANTAGONIST+ANTIBODY&rft.inventor=POSTELNEK%2C+Jennifer+R&rft.inventor=ALTURA%2C+Rachel+A&rft.inventor=PEREZ%2C+Raymond+P&rft.inventor=KLIPPEL-GIESE%2C+Anke&rft.inventor=HILT%2C+Edward&rft.inventor=ZHAO%2C+Yue&rft.inventor=SANGHAVI%2C+Kinjal&rft.date=2019-10-17&rft.externalDBID=A1&rft.externalDocID=WO2019200256A1